Maribel Villaseñor Landeros

Population health is undergoing a significant transition characterized by the interaction of emerging risks, structural inequalities, and evolving public health responses. This review analyzes recent evidence (2020 onward) to explore how contemporary health systems are adapting to complex and interconnected challenges, including pandemics, climate change, globalization, and the dual burden of communicable and non-communicable diseases. A structured narrative review with a systematic approach was conducted, integrating high-impact studies to identify key patterns and determinants influencing population health outcomes. The findings reveal that health inequalities remain a central driver of vulnerability, while governance capacity, environmental pressures, and technological advancements play critical roles in shaping system responsiveness. Adaptive public health models—defined by flexibility, data-driven decision-making, intersectoral coordination, and community engagement—emerge as essential frameworks for improving resilience and equity. Evidence from Mexico, Colombia, and Ecuador highlights the importance of context-specific strategies within shared regional challenges. Overall, the study emphasizes the need for integrated, adaptive, and system-oriented approaches to effectively address the complexity of modern population health and to strengthen public health systems in a rapidly changing global environment.

Low-grade inflammation has emerged as a central biological mechanism linking multiple chronic conditions commonly encountered in internal medicine. Increasing evidence indicates that metabolic and cardiovascular diseases are not isolated entities, but interconnected manifestations of a shared immunometabolic dysfunction. In this context, type 2 diabetes mellitus occupies a pivotal role, functioning both as a consequence and a driver of chronic inflammatory activation. This narrative review synthesizes experimental, epidemiological, and clinical evidence to analyze low-grade inflammation as a cross-cutting mechanism underlying chronic disease, with particular emphasis on its relationship with insulin resistance, metabolic dysregulation, and cardiovascular risk. The findings demonstrate a progressive increase in inflammatory burden across the metabolic continuum, a close association between inflammation and insulin resistance, and a consistent convergence between inflammatory activity and cardiovascular risk. These patterns are preserved across different population contexts, supporting the global relevance of inflammation-centered models of chronic disease. Conceptualizing diabetes as an immunometabolic disorder within this framework offers an integrative perspective that may enhance clinical reasoning, prevention strategies, and medical education in internal medicine.

Preventive Medicine 2.0 represents a paradigm shift in public health, driven by the integration of digital technologies, big data analytics, and artificial intelligence. This study provides a comprehensive review of the role of integrated digital health data systems in improving preventive strategies and community-level health outcomes. A structured analysis of high-impact literature published from 2020 onwards was conducted, focusing on key domains such as data integration, interoperability, artificial intelligence, and digital health implementation. The findings indicate that while foundational components such as electronic health records and big data systems have achieved significant adoption, critical gaps remain in interoperability and advanced analytics. The results demonstrate that higher levels of data integration are associated with substantial improvements in early detection, risk stratification, and targeted interventions. However, persistent barriers—including data fragmentation, infrastructure limitations, workforce gaps, and health data poverty—continue to limit the full potential of digital health systems. The study also highlights regional disparities, particularly in Latin America, where countries such as Mexico, Colombia, and Ecuador show progress but remain in transitional stages of digital transformation. The findings emphasize that the success of Preventive Medicine 2.0 depends not only on technological advancements but also on governance, equity, and system-level integration. Ultimately, this work supports the need for coordinated strategies to strengthen data-driven public health systems and enhance community-level health outcomes.

Insulin resistance represents a critical stage in the development of type 2 diabetes mellitus (T2DM), frequently preceding clinical diagnosis by several years. Increasing evidence indicates that the gut–pancreas axis plays a central role in metabolic regulation through complex interactions between intestinal microbiota, microbial metabolites, inflammatory signaling, and pancreatic endocrine function. This review synthesizes current scientific evidence on the contribution of the gut–pancreas axis to insulin resistance, with particular emphasis on emerging microbiome-related biomarkers with potential predictive value for T2DM. A structured narrative review of peer-reviewed international literature was conducted, integrating experimental, observational, metagenomic, and interventional studies addressing gut microbiota composition, functional metabolic outputs, inflammatory pathways, and biomarker development. The findings indicate that functional microbial products, especially short-chain fatty acids, along with metabolic inflammation and endotoxemia-related mechanisms, are consistently associated with impaired insulin sensitivity. Metagenomic signatures and barrier-related interactions further support a systems-level role of the gut microbiome in metabolic dysregulation, while dietary and microbiota-based interventions demonstrate the modifiability of these pathways. Collectively, the evidence supports the gut–pancreas axis as a biologically coherent and clinically relevant framework for early risk stratification of insulin resistance. Integrative biomarker models combining microbial, inflammatory, and conventional metabolic indicators may enhance early prediction and inform preventive strategies across diverse populations.